Creo Medical Group PLC (CREO) - Net Assets

Latest as of December 2025: GBX50.00 Million GBX ≈ $6.08K USD

Based on the latest financial reports, Creo Medical Group PLC (CREO) has net assets worth GBX50.00 Million GBX (≈ $6.08K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX59.10 Million ≈ $7.19K USD) and total liabilities (GBX9.10 Million ≈ $1.11K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore CREO total assets for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	GBX50.00 Million
% of Total Assets	84.6%
Annual Growth Rate	N/A
5-Year Change	-31.8%
10-Year Change	241.24%
Growth Volatility	381.98

Creo Medical Group PLC - Net Assets Trend (2005–2025)

This chart illustrates how Creo Medical Group PLC's net assets have evolved over time, based on quarterly financial data. Check tangible equity quality of Creo Medical Group PLC to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Creo Medical Group PLC (2005–2025)

The table below shows the annual net assets of Creo Medical Group PLC from 2005 to 2025. For live valuation and market cap data, see CREO stock market capitalisation.

Year	Net Assets	Change
2025-12-31	GBX50.00 Million ≈ $6.08K	+17.92%
2024-12-31	GBX42.40 Million ≈ $5.16K	-29.10%
2023-12-31	GBX59.80 Million ≈ $7.28K	+21.05%
2022-12-31	GBX49.40 Million ≈ $6.01K	-32.62%
2021-12-31	GBX73.32 Million ≈ $8.92K	+16.74%
2020-12-31	GBX62.81 Million ≈ $7.64K	-24.02%
2019-12-31	GBX82.66 Million ≈ $10.06K	+73.25%
2018-12-31	GBX47.71 Million ≈ $5.81K	+551.03%
2018-06-30	GBX7.33 Million ≈ $891.73	-49.98%
2017-06-30	GBX14.65 Million ≈ $1.78K	+799.39%
2016-06-30	GBX1.63 Million ≈ $198.22	-49.44%
2016-02-29	GBX3.22 Million ≈ $392.03	+330.52%
2015-02-28	GBX748.41K ≈ $91.06	-45.56%
2014-02-28	GBX1.37 Million ≈ $167.26	+1116.51%
2008-02-29	GBX113.00K ≈ $13.75	+841.67%
2007-02-28	GBX12.00K ≈ $1.46	+500.00%
2006-02-28	GBX-3.00K ≈ $-0.37	+75.00%
2005-02-28	GBX-12.00K ≈ $-1.46	--

Equity Component Analysis

This analysis shows how different components contribute to Creo Medical Group PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 1281766.7% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	GBX400.00K	0.80%
Other Comprehensive Income	GBX11.50 Million	23.00%
Other Components	GBX191.90 Million	383.80%
Total Equity	GBX50.00 Million	100.00%

Creo Medical Group PLC Competitors by Market Cap

The table below lists competitors of Creo Medical Group PLC ranked by their market capitalization.

Company	Market Cap
Geiger Counter Limited LSE:GCL	$765.33K
B Yair Building Corporation 1988 Ltd TA:BYAR	$768.74K
Sentoria Group Bhd KLSE:5213	$770.00K
AI Era Corp. NASDAQ:ABQQD	$772.11K
Xplore Resources Corp V:XPLR	$761.02K
Arkle Resources PLC STU:48O	$760.55K
Troubadour Resources Inc V:TR	$760.30K
Arcandor AG DU:ARO	$759.68K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Creo Medical Group PLC's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 42,400,000 to 50,000,000, a change of 7,600,000 (17.9%).
Net income of 5,300,000 contributed positively to equity growth.
Share repurchases of 100,000 reduced equity.
Other comprehensive income decreased equity by 11,599,999.
Other factors increased equity by 13,999,999.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	GBX5.30 Million	+10.6%
Share Repurchases	GBX100.00K	-0.2%
Other Comprehensive Income	GBX-11.60 Million	-23.2%
Other Changes	GBX14.00 Million	+28.0%
Total Change	GBX-	17.92%

Book Value vs Market Value Analysis

This analysis compares Creo Medical Group PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 106.20x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 784.30x to 106.20x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2014-02-28	GBX0.02	GBX12.88	x
2015-02-28	GBX0.01	GBX12.88	x
2016-02-29	GBX0.04	GBX12.88	x
2017-06-30	GBX0.24	GBX12.88	x
2018-06-30	GBX0.09	GBX12.88	x
2018-12-31	GBX0.51	GBX12.88	x
2019-12-31	GBX0.66	GBX12.88	x
2020-12-31	GBX0.39	GBX12.88	x
2021-12-31	GBX0.43	GBX12.88	x
2022-12-31	GBX0.26	GBX12.88	x
2023-12-31	GBX0.19	GBX12.88	x
2024-12-31	GBX0.12	GBX12.88	x
2025-12-31	GBX0.12	GBX12.88	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Creo Medical Group PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 10.60%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 88.33%
• Asset Turnover: 0.10x
• Equity Multiplier: 1.18x
Recent ROE (10.60%) is above the historical average (-76.11%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	-123.43%	-211.43%	0.49x	1.18x	GBX-1.83 Million
2015	-318.28%	0.00%	0.00x	1.40x	GBX-2.46 Million
2016	-103.34%	-622.74%	0.14x	1.17x	GBX-3.65 Million
2016	-99.02%	-317.43%	0.21x	1.48x	GBX-1.78 Million
2017	-53.00%	0.00%	0.00x	1.10x	GBX-9.23 Million
2018	-114.73%	0.00%	0.00x	1.31x	GBX-9.14 Million
2018	-20.69%	0.00%	0.00x	1.04x	GBX-14.64 Million
2019	-19.25%	-118096.56%	0.00x	1.07x	GBX-24.18 Million
2020	-32.35%	-215.46%	0.10x	1.47x	GBX-26.60 Million
2021	-33.55%	-97.75%	0.25x	1.37x	GBX-31.93 Million
2022	-54.52%	-99.14%	0.36x	1.52x	GBX-31.88 Million
2023	-36.29%	-70.45%	0.40x	1.28x	GBX-27.68 Million
2024	-67.69%	-717.50%	0.06x	1.53x	GBX-32.94 Million
2025	10.60%	88.33%	0.10x	1.18x	GBX300.00K

Industry Comparison

This section compares Creo Medical Group PLC's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $56,116,814
Average return on equity (ROE) among peers: -29.11%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Creo Medical Group PLC (CREO)	GBX50.00 Million	-123.43%	0.18x	$761.02K
AOTI Inc (AOTI)	$-5.91 Million	0.00%	0.00x	$1.26 Million
EKF Diagnostics Holdings Plc (EKF)	$78.20 Million	14.21%	0.29x	$1.35 Million
Inspiration Healthcare Group PLC (IHC)	$4.10 Million	-31.82%	0.20x	$196.37K
NIOX Group PLC (NIOX)	$83.80 Million	12.77%	0.09x	$3.20 Million
Polarean Imaging Plc (POLX)	$8.30 Million	-143.22%	0.31x	$11.75K
Rua Life Sciences PLC (RUA)	$4.11 Million	-24.36%	0.32x	$181.22K
Smith & Nephew PLC (SN)	$273.58 Million	25.01%	1.35x	$114.49 Million
Surgical Innovations Group plc (SUN)	$2.75 Million	-85.48%	0.44x	$56.75K

About Creo Medical Group PLC

LSE:CREO UK Medical Devices

Market Cap

$761.02K

GBX6.25 Billion GBX

Market Cap Rank

#30707 Global

#848 in UK

Share Price

GBX12.88

Change (1 day)

-2.83%

52-Week Range

GBX9.90 - GBX17.75

All Time High

GBX243.00